These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
274 related articles for article (PubMed ID: 38749694)
1. Study protocol: the biologics in severe chronic rhinosinusitis with nasal polyps survey. Favier V; Daveau C; Carsuzaa F; Fieux M; Vandersteen C; Castillo L; Papon JF; de Gabory L; Saroul N; Verillaud B; Rumeau C; Jankowski R; Michel J; de Bonnecaze G; Lecanu JB; Coste A; Béquignon E; Malard O; Mortuaire G BMJ Open; 2024 May; 14(5):e083112. PubMed ID: 38749694 [TBL] [Abstract][Full Text] [Related]
2. The argument against the use of dupilumab in patients with limited polyp burden in chronic rhinosinusitis with nasal polyposis (CRSwNP). Hardison SA; Senior BA J Otolaryngol Head Neck Surg; 2023 Sep; 52(1):64. PubMed ID: 37759322 [TBL] [Abstract][Full Text] [Related]
4. Efficacy and Safety of Dupilumab Versus Omalizumab in Chronic Rhinosinusitis With Nasal Polyps and Asthma: EVEREST Trial Design. De Prado Gomez PharmD MSc L; Khan Mbbs Mph AH; Peters Md AT; Bachert Md PhD C; Wagenmann Md M; Heffler Md PhD E; Hopkins BMBCh C; Hellings Md PhD PW; Zhang PhD M; Xing PhD J; Rowe Md P; Jacob-Nara Md Mph DHSc JA Am J Rhinol Allergy; 2022 Nov; 36(6):788-795. PubMed ID: 35837739 [TBL] [Abstract][Full Text] [Related]
5. Systematic literature review of the epidemiology and clinical burden of chronic rhinosinusitis with nasal polyposis. Chen S; Zhou A; Emmanuel B; Thomas K; Guiang H Curr Med Res Opin; 2020 Nov; 36(11):1897-1911. PubMed ID: 32847417 [TBL] [Abstract][Full Text] [Related]
6. Chronic rhinosinusitis with nasal polyps management in the age of biologics. Blaiss MS Allergy Asthma Proc; 2020 Nov; 41(6):413-419. PubMed ID: 33109306 [No Abstract] [Full Text] [Related]
7. Chinese Expert Consensus on the Use of Biologics in Patients with Chronic Rhinosinusitis (2022, Zhuhai). Hong HY; Chen TY; Yang QT; Sun YQ; Chen FH; Lou HF; Wang HT; Yu RL; An YF; Liu F; Wang TS; Lu MP; Qiu QH; Wang XD; Chen JJ; Meng CD; Xie ZH; Meng J; Zeng M; Xu CL; Wang Y; Yang YC; Zhang WT; Tang J; Yang YL; Xu R; Yu GD; Shi ZH; Wei X; Ye HP; Sun YN; Yu SQ; Zhang TH; Yong J; Hang W; Xu YT; Xu Y; Tan GL; Sun N; Yang G; Li YJ; Ye J; Zuo KJ; Zhang LQ; Wang XY; Yang AN; Xu YX; Liao W; Fan YP; Li HB ORL J Otorhinolaryngol Relat Spec; 2023; 85(3):128-140. PubMed ID: 37019094 [TBL] [Abstract][Full Text] [Related]
8. Treatment options for chronic rhinosinusitis with nasal polyps. Wallace DV Allergy Asthma Proc; 2021 Nov; 42(6):450-460. PubMed ID: 34871152 [No Abstract] [Full Text] [Related]
9. A comparative analysis of endoscopic sinus surgery versus biologics for treatment of chronic rhinosinusitis with nasal polyposis. Miglani A; Soler ZM; Smith TL; Mace JC; Schlosser RJ Int Forum Allergy Rhinol; 2023 Feb; 13(2):116-128. PubMed ID: 35980852 [TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of omalizumab in nasal polyposis: 2 randomized phase 3 trials. Gevaert P; Omachi TA; Corren J; Mullol J; Han J; Lee SE; Kaufman D; Ligueros-Saylan M; Howard M; Zhu R; Owen R; Wong K; Islam L; Bachert C J Allergy Clin Immunol; 2020 Sep; 146(3):595-605. PubMed ID: 32524991 [TBL] [Abstract][Full Text] [Related]
12. Role of Biologics in Chronic Rhinosinusitis With Nasal Polyposis: State of the Art Review. Kim C; Han J; Wu T; Bachert C; Fokkens W; Hellings P; Hopkins C; Lee S; Mullol J; Lee JT Otolaryngol Head Neck Surg; 2021 Jan; 164(1):57-66. PubMed ID: 32746710 [TBL] [Abstract][Full Text] [Related]
13. Biologic Therapies for Allergic Rhinitis and Nasal Polyposis. Geng B; Dilley M; Anterasian C Curr Allergy Asthma Rep; 2021 Jun; 21(6):36. PubMed ID: 34110505 [TBL] [Abstract][Full Text] [Related]
14. Reduction in healthcare resource use through 24 months following sinus surgery with steroid-eluting implants in chronic rhinosinusitis patients with and without nasal polyps: a real-world study. Hoffman V; Mulder K; Topuria I; Gawlicka AK; Kallman JE Curr Med Res Opin; 2023 Dec; 39(12):1613-1619. PubMed ID: 36994626 [TBL] [Abstract][Full Text] [Related]
15. Improvement in Olfaction in Patients With CRSwNP and Severe Asthma Taking Anti-IgE and Anti-IL-5 Biologics: A Real-Life Study. Barroso B; Valverde-Monge M; Alobid I; Olaguibel JM; Rial MJ; Quirce S; Arismendi E; Barranco P; Betancor D; Bobolea I; Cárdaba B; Cruz Carmona MJ; Curto E; Domínguez-Ortega J; González-Barcala FJ; Martínez-Rivera C; Mahíllo-Fernández I; Muñoz X; Picado C; Plaza V; Rodrigo Muñoz JM; Soto-Retes L; Valero A; Del Pozo V; Mullol J; Sastre J J Investig Allergol Clin Immunol; 2023 Feb; 33(1):37-44. PubMed ID: 35416154 [TBL] [Abstract][Full Text] [Related]
16. Dupilumab in the treatment of severe uncontrolled chronic rhinosinusitis with nasal polyps (CRSwNP): A multicentric observational Phase IV real-life study (DUPIREAL). De Corso E; Pasquini E; Trimarchi M; La Mantia I; Pagella F; Ottaviano G; Garzaro M; Pipolo C; Torretta S; Seccia V; Cantone E; Ciofalo A; Lucidi D; Fadda GL; Pafundi PC; Settimi S; Montuori C; Anastasi F; Pagliuca G; Ghidini A; Cavaliere C; Maffei M; Bussu F; Gallo S; Canevari FRM; Paludetti G; Galli J; Allergy; 2023 Oct; 78(10):2669-2683. PubMed ID: 37203259 [TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of dupilumab in patients with severe chronic rhinosinusitis with nasal polyps (LIBERTY NP SINUS-24 and LIBERTY NP SINUS-52): results from two multicentre, randomised, double-blind, placebo-controlled, parallel-group phase 3 trials. Bachert C; Han JK; Desrosiers M; Hellings PW; Amin N; Lee SE; Mullol J; Greos LS; Bosso JV; Laidlaw TM; Cervin AU; Maspero JF; Hopkins C; Olze H; Canonica GW; Paggiaro P; Cho SH; Fokkens WJ; Fujieda S; Zhang M; Lu X; Fan C; Draikiwicz S; Kamat SA; Khan A; Pirozzi G; Patel N; Graham NMH; Ruddy M; Staudinger H; Weinreich D; Stahl N; Yancopoulos GD; Mannent LP Lancet; 2019 Nov; 394(10209):1638-1650. PubMed ID: 31543428 [TBL] [Abstract][Full Text] [Related]
18. Otitis media in severe asthma associated with chronic rhinosinusitis with nasal polyps: a new therapeutic target for biologics. Bartier S; Béquignon E; Thibaut de Ménonville C; Verillaud B; Evrard D; Léger M; Papon JF; Coste A; Taillé C J Asthma; 2023 Jan; 60(1):139-144. PubMed ID: 35073225 [No Abstract] [Full Text] [Related]
19. Type 2 Biomarkers for the Indication and Response to Biologics in CRSwNP. Guo CL; Liu FF; Wang DY; Liu Z Curr Allergy Asthma Rep; 2023 Dec; 23(12):703-713. PubMed ID: 37987873 [TBL] [Abstract][Full Text] [Related]
20. Biologics in Chronic Rhinosinusitis: Current and Emerging. Boyd JT; Khanwalkar AR Immunol Allergy Clin North Am; 2024 Nov; 44(4):657-671. PubMed ID: 39389716 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]